PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-6.23%
Negative revenue growth while MRVL stands at 7.74%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-7.26%
Negative gross profit growth while MRVL is at 9.39%. Joel Greenblatt would examine cost competitiveness or demand decline.
-9.56%
Negative EBIT growth while MRVL is at 101.43%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-11.12%
Negative operating income growth while MRVL is at 101.43%. Joel Greenblatt would press for urgent turnaround measures.
-12.95%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-12.96%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-13.15%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
0.11%
Slight or no buybacks while MRVL is reducing shares. John Neff might see a missed opportunity if the company’s stock is cheap.
No Data
No Data available this quarter, please select a different quarter.
0.07%
Dividend growth under 50% of MRVL's 2.26%. Michael Burry might suspect more pressing needs for cash or weaker earnings power.
-43.19%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-83.44%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
85.25%
10Y revenue/share CAGR above 1.5x MRVL's 27.20%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
25.26%
5Y revenue/share CAGR under 50% of MRVL's 51.91%. Michael Burry would suspect a significant competitive gap or product weakness.
35.02%
3Y revenue/share CAGR under 50% of MRVL's 73.72%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
293.27%
Positive long-term OCF/share growth while MRVL is negative. John Neff would see a structural advantage in sustained cash generation.
13.06%
Positive OCF/share growth while MRVL is negative. John Neff might see a comparative advantage in operational cash viability.
39.92%
Positive 3Y OCF/share CAGR while MRVL is negative. John Neff might see a big short-term edge in operational efficiency.
475.86%
Positive 10Y CAGR while MRVL is negative. John Neff might see a substantial advantage in bottom-line trajectory.
35.51%
Positive 5Y CAGR while MRVL is negative. John Neff might view this as a strong mid-term relative advantage.
49.34%
Positive short-term CAGR while MRVL is negative. John Neff would see a clear advantage in near-term profit trajectory.
69.87%
10Y equity/share CAGR at 50-75% of MRVL's 119.95%. Martin Whitman would note a lag in capital accumulation vs. the competitor.
55.24%
Below 50% of MRVL's 137.36%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
102.31%
3Y equity/share CAGR 1.25-1.5x MRVL's 70.13%. Bruce Berkowitz confirms timely buybacks or margin improvements drive stronger near-term equity growth.
491.84%
Dividend/share CAGR of 491.84% while MRVL is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
99.55%
5Y dividend/share CAGR above 1.5x MRVL's 3.20%. David Dodd checks if the firm's mid-term cash flows justify a faster dividend growth rate.
37.31%
3Y dividend/share CAGR above 1.5x MRVL's 2.58%. David Dodd sees a superior short-term capital return strategy if supported by stable earnings.
-0.95%
Firm’s AR is declining while MRVL shows 13.59%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
19.26%
Inventory growth well above MRVL's 15.99%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
7.40%
Positive asset growth while MRVL is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
4.45%
BV/share growth above 1.5x MRVL's 0.38%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
11.53%
We have some new debt while MRVL reduces theirs. John Neff sees the competitor as more cautious unless our expansions pay off strongly.
4.84%
R&D dropping or stable vs. MRVL's 11.23%. David Dodd sees near-term margin benefits if the product pipeline is already strong.
10.49%
We expand SG&A while MRVL cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.